Table 4.
Planned effect estimates in current or most recent pragmatic trial | |||
---|---|---|---|
Intention-to-treat as primary analysis (n=12) |
Intention-to-treat as secondary analysis (n=3) |
Per-protocol as secondary analysis (n=7) |
|
Prefer this effect in an effectiveness (superiority) trial because: | |||
The causal question it answers | 9 | 3 | 4 |
Always estimate this effect | 6 | 1 | 0 |
Ability to estimate without bias | 5 | 2 | 0 |
Ease of communicating to others | 2 | 1 | 1 |
Ease of estimation | 2 | 1 | 0 |
Trial-specific factors | 2 | 0 | 0 |
Other | -- | -- | 2 |
Familiarity with using post-randomization factors to adjust for loss to follow-up | |||
Not familiar | 3 | 1 | 1 |
Somewhat familiar | 8 | 2 | 5 |
Very familiar | 1 | 0 | 1 |
Familiarity with using post-randomization factors to adjust for adherence | |||
Not familiar | 7 | 3 | 3 |
Somewhat familiar | 3 | 0 | 3 |
Very familiar | 1 | 0 | 1 |